Polymorphisms to Predict Outcome to the Tyrosine Kinase Inhibitors Gefitinib, Erlotinib, Sorafenib and Sunitinib

L. Erdem, E. Giovannetti, L.G. Leon, R. Honeywell, G.J. Peters

Research output: Contribution to journal › Article › Academic › peer-review

24 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	1649-1659
Journal	Current topics in medicinal chemistry
Volume	12
Issue number	15
DOIs	https://doi.org/10.2174/156802612803531333
Publication status	Published - 2012

Access to Document

@article{8bd5a4f6aa934593851d245975d3c178,

title = "Polymorphisms to Predict Outcome to the Tyrosine Kinase Inhibitors Gefitinib, Erlotinib, Sorafenib and Sunitinib",

author = "L. Erdem and E. Giovannetti and L.G. Leon and R. Honeywell and G.J. Peters",

year = "2012",

doi = "https://doi.org/10.2174/156802612803531333",

language = "Undefined/Unknown",

volume = "12",

pages = "1649--1659",

journal = "Current topics in medicinal chemistry",

issn = "1568-0266",

publisher = "Bentham Science Publishers B.V.",

number = "15",

}

TY - JOUR

T1 - Polymorphisms to Predict Outcome to the Tyrosine Kinase Inhibitors Gefitinib, Erlotinib, Sorafenib and Sunitinib

AU - Erdem, L.

AU - Giovannetti, E.

AU - Leon, L.G.

AU - Honeywell, R.

AU - Peters, G.J.

PY - 2012

Y1 - 2012

U2 - https://doi.org/10.2174/156802612803531333

DO - https://doi.org/10.2174/156802612803531333

M3 - Article

SN - 1568-0266

VL - 12

SP - 1649

EP - 1659

JO - Current topics in medicinal chemistry

JF - Current topics in medicinal chemistry

IS - 15

ER -